Gliclazide protects human islet beta‐cells from apoptosis induced by intermittent high glucose

Abstract

Therefore, gliclazide protected human beta-cells from apoptosis induced by intermittent high glucose, and this effect was likely to be due, at least in part, to the anti-oxidant properties of the molecule.